KLAC vs LENZ · P/E 55, rev $13.58B vs rev $7.4M
KLA Corporation (KLAC) versus LENZ Therapeutics Inc (LENZ) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. LENZ currently screens at market cap $223.6M.
Not investment advice. Open the KLAC and LENZ stock pages for the full models.
Not investment advice.